Erlonat Tablet (Erlotinib) – EGFR-Positive Lung & Pancreatic Cancer Treatment

Erlonat (Erlotinib) (generic equivalent to Tarceva) is a prescription targeted oncology medication for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations and pancreatic cancer. As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Erlotinib (150mg)
Manufacturer: Natco Pharma Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.